FMR LLC
Insider CIK 315066 · INSM 10% owner · XOOM 10% owner · DTIL · TTPH 10% owner · GTAT 10% owner · MRSN · PTI 10% owner · IRWD 10% owner · GNRC 10% owner · CHRS 10% owner · RARE 10% owner · AVLN 10% owner · ACRS 10% owner · MNLO · FLYW · RGNX 10% owner · DMTX 10% owner · BPMC 10% owner · VRAY 10% owner · CRBU · UMRX · TOST · DNLI · SURF 10% owner · RLYB · BEAM 10% owner · ORTX 10% owner · TSBX 10% owner · SANA 10% owner · XLO · VERV 10% owner · NMRA · GPCR 10% owner · PRME · NONE 10% owner · BCAX · MTSR 10% owner · EXA 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| GPCR Structure Therapeutics Inc | S Sale deriv | 2026-07-22 | 2026-07-24 | 1,367 | $50.07 | $68.4K | 1,369 | SEC↗ |
| GPCR Structure Therapeutics Inc | S Sale deriv | 2026-07-22 | 2026-07-24 | 16,085 | $50.07 | $805.4K | 16,086 | SEC↗ |
| BEAM Beam Therapeutics Inc. | S Sale | 2026-06-26 | 2026-06-29 | 251,488 | $35.26 | $8.87M | 854,583 | SEC↗ |
| BEAM Beam Therapeutics Inc. | S Sale | 2026-06-25 | 2026-06-29 | 33,372 | $35.12 | $1.17M | 1,106,071 | SEC↗ |
| AVLN Avalyn Pharma Inc. | C Conversion deriv | 2026-05-01 | 2026-05-05 | 377,948 | — | $0 | 0 | SEC↗ |
| AVLN Avalyn Pharma Inc. | C Conversion deriv | 2026-05-01 | 2026-05-05 | 225,843 | — | $0 | 0 | SEC↗ |
| AVLN Avalyn Pharma Inc. | C Conversion deriv | 2026-05-01 | 2026-05-05 | 872,868 | — | $0 | 0 | SEC↗ |
| AVLN Avalyn Pharma Inc. | C Conversion deriv | 2026-05-01 | 2026-05-05 | 80,291 | — | $0 | 0 | SEC↗ |
| AVLN Avalyn Pharma Inc. | C Conversion deriv | 2026-05-01 | 2026-05-05 | 727,585 | — | $0 | 0 | SEC↗ |
| AVLN Avalyn Pharma Inc. | C Conversion | 2026-05-01 | 2026-05-05 | 727,585 | — | $0 | 727,585 | SEC↗ |
| AVLN Avalyn Pharma Inc. | C Conversion | 2026-05-01 | 2026-05-05 | 80,291 | — | $0 | 807,876 | SEC↗ |
| AVLN Avalyn Pharma Inc. | C Conversion | 2026-05-01 | 2026-05-05 | 872,868 | — | $0 | 1,680,744 | SEC↗ |
| AVLN Avalyn Pharma Inc. | C Conversion | 2026-05-01 | 2026-05-05 | 225,843 | — | $0 | 1,906,587 | SEC↗ |
| AVLN Avalyn Pharma Inc. | C Conversion | 2026-05-01 | 2026-05-05 | 377,948 | — | $0 | 2,284,535 | SEC↗ |
| GPCR Structure Therapeutics Inc | S Sale deriv | 2026-04-14 | 2026-04-16 | 16,085 | $55.07 | $885.8K | 32,171 | SEC↗ |
| GPCR Structure Therapeutics Inc | S Sale deriv | 2026-04-14 | 2026-04-16 | 1,367 | $55.07 | $75.3K | 2,736 | SEC↗ |
| GPCR Structure Therapeutics Inc | S Sale deriv | 2026-01-15 | 2026-01-20 | 552 | $84.22 | $46.5K | 4,123 | SEC↗ |
| GPCR Structure Therapeutics Inc | S Sale deriv | 2026-01-15 | 2026-01-20 | 465 | $82.10 | $38.2K | 5,005 | SEC↗ |
| GPCR Structure Therapeutics Inc | S Sale deriv | 2026-01-15 | 2026-01-20 | 330 | $83.35 | $27.5K | 4,675 | SEC↗ |
| GPCR Structure Therapeutics Inc | S Sale deriv | 2026-01-15 | 2026-01-20 | 20 | $85.04 | $1.7K | 4,103 | SEC↗ |
| GPCR Structure Therapeutics Inc | S Sale deriv | 2026-01-15 | 2026-01-20 | 5,477 | $82.10 | $449.7K | 58,864 | SEC↗ |
| GPCR Structure Therapeutics Inc | S Sale deriv | 2026-01-15 | 2026-01-20 | 3,880 | $83.35 | $323.4K | 54,984 | SEC↗ |
| GPCR Structure Therapeutics Inc | S Sale deriv | 2026-01-15 | 2026-01-20 | 230 | $85.04 | $19.6K | 48,256 | SEC↗ |
| GPCR Structure Therapeutics Inc | S Sale deriv | 2026-01-15 | 2026-01-20 | 6,498 | $84.22 | $547.3K | 48,486 | SEC↗ |
| GPCR Structure Therapeutics Inc | S Sale deriv | 2025-12-08 | 2025-12-10 | 1,414 | $61.05 | $86.3K | 1,321 | SEC↗ |
| GPCR Structure Therapeutics Inc | S Sale deriv | 2025-12-08 | 2025-12-10 | 709 | $92.52 | $65.6K | 3,393 | SEC↗ |
| GPCR Structure Therapeutics Inc | S Sale deriv | 2025-12-08 | 2025-12-10 | 183 | $94.00 | $17.2K | 3,210 | SEC↗ |
| GPCR Structure Therapeutics Inc | S Sale deriv | 2025-12-08 | 2025-12-10 | 16,635 | $61.05 | $1.02M | 15,535 | SEC↗ |
| GPCR Structure Therapeutics Inc | S Sale deriv | 2025-12-08 | 2025-12-10 | 5,589 | $94.61 | $528.8K | 32,170 | SEC↗ |
| GPCR Structure Therapeutics Inc | S Sale deriv | 2025-12-08 | 2025-12-10 | 2,159 | $94.00 | $202.9K | 37,759 | SEC↗ |
| GPCR Structure Therapeutics Inc | S Sale deriv | 2025-12-08 | 2025-12-10 | 8,337 | $92.52 | $771.3K | 39,918 | SEC↗ |
| GPCR Structure Therapeutics Inc | S Sale deriv | 2025-12-08 | 2025-12-10 | 1,320 | $61.45 | $81.1K | 1 | SEC↗ |
| GPCR Structure Therapeutics Inc | S Sale deriv | 2025-12-08 | 2025-12-10 | 15,535 | $61.45 | $954.6K | 0 | SEC↗ |
| GPCR Structure Therapeutics Inc | S Sale deriv | 2025-12-08 | 2025-12-10 | 475 | $94.61 | $44.9K | 2,735 | SEC↗ |
| MTSR Metsera, Inc. | J Other | 2025-11-13 | 2025-11-17 | 2,230,450 | — | $0 | 0 | SEC↗ |
| MTSR Metsera, Inc. | J Other | 2025-11-13 | 2025-11-17 | 3,010 | — | $0 | 0 | SEC↗ |
| MTSR Metsera, Inc. | G Gift | 2025-11-10 | 2025-11-12 | 860,722 | — | $0 | 2,230,450 | SEC↗ |
| MTSR Metsera, Inc. | J Other | 2025-11-03 | 2025-11-05 | 2,356,274 | — | $0 | 2,356,274 | SEC↗ |
| MTSR Metsera, Inc. | J Other | 2025-11-03 | 2025-11-05 | 2,115 | — | $0 | 3,010 | SEC↗ |
| MTSR Metsera, Inc. | J Other | 2025-11-03 | 2025-11-05 | 47,843 | — | $0 | 0 | SEC↗ |
| MTSR Metsera, Inc. | J Other | 2025-11-03 | 2025-11-05 | 2,356,081 | — | $0 | 0 | SEC↗ |
| MTSR Metsera, Inc. | J Other | 2025-11-03 | 2025-11-05 | 3,189,540 | — | $0 | 0 | SEC↗ |
| MTSR Metsera, Inc. | J Other | 2025-11-03 | 2025-11-05 | 2,617,340 | — | $0 | 3,091,172 | SEC↗ |
| MTSR Metsera, Inc. | S Sale | 2025-11-03 | 2025-11-05 | 193 | $61.23 | $11.8K | 2,356,081 | SEC↗ |
| MTSR Metsera, Inc. | J Other | 2025-11-03 | 2025-11-05 | 47,843 | — | $0 | 47,843 | SEC↗ |
| BEAM Beam Therapeutics Inc. | S Sale | 2025-10-27 | 2025-10-29 | 459 | $26.68 | $12.2K | 14 | SEC↗ |
| MTSR Metsera, Inc. | G Gift | 2025-10-06 | 2025-10-08 | 633,715 | — | $0 | 473,832 | SEC↗ |
| BEAM Beam Therapeutics Inc. | G Gift | 2025-10-06 | 2025-10-08 | 1,232,434 | — | $0 | 841,231 | SEC↗ |
| MTSR Metsera, Inc. | S Sale | 2025-09-02 | 2025-09-04 | 268 | $36.00 | $9.6K | 0 | SEC↗ |
| MTSR Metsera, Inc. | J Other | 2025-09-02 | 2025-09-04 | 1,350,000 | — | $0 | 3,189,540 | SEC↗ |
| MTSR Metsera, Inc. | J Other | 2025-09-02 | 2025-09-04 | 997,044 | — | $0 | 268 | SEC↗ |
| MTSR Metsera, Inc. | J Other | 2025-09-02 | 2025-09-04 | 1,134,258 | — | $0 | 1,134,258 | SEC↗ |
| MTSR Metsera, Inc. | J Other | 2025-09-02 | 2025-09-04 | 20,250 | — | $0 | 20,250 | SEC↗ |
| MTSR Metsera, Inc. | J Other | 2025-09-02 | 2025-09-04 | 20,250 | — | $0 | 0 | SEC↗ |
| MTSR Metsera, Inc. | J Other | 2025-09-02 | 2025-09-04 | 895 | — | $0 | 895 | SEC↗ |
| MTSR Metsera, Inc. | J Other | 2025-09-02 | 2025-09-04 | 997,312 | — | $0 | 997,312 | SEC↗ |
| MTSR Metsera, Inc. | J Other | 2025-09-02 | 2025-09-12 | 1,107,547 | — | $0 | 1,107,547 | SEC↗ |
| GPCR Structure Therapeutics Inc | S Sale deriv | 2025-07-30 | 2025-08-01 | 26,310 | $17.87 | $470.2K | 1,515,558 | SEC↗ |
| BEAM Beam Therapeutics Inc. | S Sale | 2025-07-30 | 2025-08-01 | 48,374 | $20.50 | $991.7K | 2,073,665 | SEC↗ |
| GPCR Structure Therapeutics Inc | S Sale deriv | 2025-02-06 | 2025-02-10 | 41 | $30.54 | $1.3K | 0 | SEC↗ |
| MTSR Metsera, Inc. | C Conversion deriv | 2025-02-03 | 2025-02-05 | 3,120,934 | — | $0 | 0 | SEC↗ |
| MTSR Metsera, Inc. | C Conversion deriv | 2025-02-03 | 2025-02-05 | 1,418,606 | — | $0 | 0 | SEC↗ |
| MTSR Metsera, Inc. | C Conversion | 2025-02-03 | 2025-02-05 | 3,120,934 | — | $0 | 4,539,540 | SEC↗ |
| MTSR Metsera, Inc. | C Conversion | 2025-02-03 | 2025-02-05 | 1,418,606 | — | $0 | 1,418,606 | SEC↗ |
| SANA Sana Biotechnology, Inc. | S Sale | 2025-01-08 | 2025-01-10 | 25,000 | $6.50 | $162.5K | 4,707,423 | SEC↗ |
| SANA Sana Biotechnology, Inc. | S Sale | 2025-01-08 | 2025-01-10 | 1,000 | $7.26 | $7.3K | 4,541,511 | SEC↗ |
| SANA Sana Biotechnology, Inc. | S Sale | 2025-01-08 | 2025-01-10 | 164,912 | $6.71 | $1.11M | 4,542,511 | SEC↗ |
| SANA Sana Biotechnology, Inc. | S Sale | 2025-01-08 | 2025-01-10 | 100,000 | $6.11 | $611.0K | 4,732,423 | SEC↗ |
| BCAX Bicara Therapeutics Inc. | C Conversion deriv | 2024-09-16 | 2024-09-18 | 392,085 | — | $0 | 0 | SEC↗ |
| BCAX Bicara Therapeutics Inc. | C Conversion deriv | 2024-09-16 | 2024-09-18 | 10,818 | — | $0 | 0 | SEC↗ |
| BCAX Bicara Therapeutics Inc. | C Conversion deriv | 2024-09-16 | 2024-09-18 | 712,430 | — | $0 | 0 | SEC↗ |
| BCAX Bicara Therapeutics Inc. | C Conversion | 2024-09-16 | 2024-09-18 | 392,085 | — | $0 | 1,115,333 | SEC↗ |
| BCAX Bicara Therapeutics Inc. | C Conversion | 2024-09-16 | 2024-09-18 | 10,818 | — | $0 | 10,818 | SEC↗ |
| BCAX Bicara Therapeutics Inc. | C Conversion | 2024-09-16 | 2024-09-18 | 712,430 | — | $0 | 723,248 | SEC↗ |
| GPCR Structure Therapeutics Inc | S Sale deriv | 2024-03-14 | 2024-03-18 | 21,997 | $35.00 | $769.9K | 1,541,868 | SEC↗ |
| BEAM Beam Therapeutics Inc. | S Sale | 2024-02-14 | 2024-02-15 | 854,323 | $30.51 | $26.07M | 1,281,188 | SEC↗ |
| BEAM Beam Therapeutics Inc. | S Sale | 2024-02-14 | 2024-02-15 | 45,677 | $31.34 | $1.43M | 1,235,511 | SEC↗ |
| GPCR Structure Therapeutics Inc | S Sale deriv | 2024-02-13 | 2024-02-15 | 525 | $47.24 | $24.8K | 1,563,865 | SEC↗ |
| BEAM Beam Therapeutics Inc. | S Sale | 2024-02-13 | 2024-02-15 | 1,155 | $30.93 | $35.7K | 2,771,913 | SEC↗ |
| BEAM Beam Therapeutics Inc. | S Sale | 2024-02-13 | 2024-02-15 | 410 | $30.28 | $12.4K | 2,773,068 | SEC↗ |
| GPCR Structure Therapeutics Inc | J Other deriv | 2023-12-22 | 2023-12-27 | 25,410 | — | $0 | 1,564,390 | SEC↗ |
| BEAM Beam Therapeutics Inc. | J Other | 2023-12-22 | 2023-12-27 | 29,549 | — | $0 | 2,773,478 | SEC↗ |
| GPCR Structure Therapeutics Inc | S Sale deriv | 2023-12-05 | 2023-12-07 | 1,368 | $62.46 | $85.4K | 2,733 | SEC↗ |
| GPCR Structure Therapeutics Inc | S Sale deriv | 2023-12-05 | 2023-12-07 | 16,086 | $62.46 | $1.00M | 32,169 | SEC↗ |
| NONE Fidelity Private Credit Fu | P Buy | 2023-11-29 | 2023-11-29 | 392 | $25.54 | $10.0K | 392 | SEC↗ |
| NONE Fidelity Private Credit Fu | P Buy | 2023-11-29 | 2023-11-29 | 392 | $25.54 | $10.0K | 392 | SEC↗ |
| GPCR Structure Therapeutics Inc | S Sale deriv | 2023-10-18 | 2023-10-23 | 1,368 | $65.64 | $89.8K | 4,101 | SEC↗ |
| GPCR Structure Therapeutics Inc | S Sale deriv | 2023-10-18 | 2023-10-23 | 16,086 | $65.64 | $1.06M | 48,255 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | C Conversion deriv | 2023-09-19 | 2023-09-21 | 84,965 | — | $0 | 0 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | C Conversion deriv | 2023-09-19 | 2023-09-21 | 3,475,646 | — | $0 | 0 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | C Conversion deriv | 2023-09-19 | 2023-09-21 | 63,724 | — | $0 | 0 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | C Conversion deriv | 2023-09-19 | 2023-09-21 | 88,289 | — | $0 | 0 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | C Conversion | 2023-09-19 | 2023-09-21 | 88,289 | — | $0 | 88,289 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | C Conversion | 2023-09-19 | 2023-09-21 | 63,724 | — | $0 | 63,724 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | C Conversion | 2023-09-19 | 2023-09-21 | 84,965 | — | $0 | 5,472,340 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | C Conversion | 2023-09-19 | 2023-09-21 | 3,475,646 | — | $0 | 5,387,375 | SEC↗ |
| TSBX Turnstone Biologics Corp. | C Conversion deriv | 2023-07-25 | 2023-07-27 | 106,496 | — | $0 | 0 | SEC↗ |
| TSBX Turnstone Biologics Corp. | C Conversion deriv | 2023-07-25 | 2023-07-27 | 150,809 | — | $0 | 0 | SEC↗ |
| TSBX Turnstone Biologics Corp. | C Conversion deriv | 2023-07-25 | 2023-07-27 | 483,684 | — | $0 | 0 | SEC↗ |
| TSBX Turnstone Biologics Corp. | C Conversion deriv | 2023-07-25 | 2023-07-27 | 296,396 | — | $0 | 0 | SEC↗ |
| TSBX Turnstone Biologics Corp. | C Conversion deriv | 2023-07-25 | 2023-07-27 | 4,939 | — | $0 | 0 | SEC↗ |
| TSBX Turnstone Biologics Corp. | C Conversion deriv | 2023-07-25 | 2023-07-27 | 91,663 | — | $0 | 0 | SEC↗ |
| TSBX Turnstone Biologics Corp. | C Conversion | 2023-07-25 | 2023-07-27 | 4,939 | — | $0 | 4,939 | SEC↗ |
| TSBX Turnstone Biologics Corp. | C Conversion | 2023-07-25 | 2023-07-27 | 296,396 | — | $0 | 296,396 | SEC↗ |
| TSBX Turnstone Biologics Corp. | C Conversion | 2023-07-25 | 2023-07-27 | 483,684 | — | $0 | 832,652 | SEC↗ |
| TSBX Turnstone Biologics Corp. | C Conversion | 2023-07-25 | 2023-07-27 | 150,809 | — | $0 | 348,968 | SEC↗ |
| TSBX Turnstone Biologics Corp. | C Conversion | 2023-07-25 | 2023-07-27 | 106,496 | — | $0 | 198,159 | SEC↗ |
| TSBX Turnstone Biologics Corp. | C Conversion | 2023-07-25 | 2023-07-27 | 91,663 | — | $0 | 91,663 | SEC↗ |
| NONE Fidelity Private Credit Fu | P Buy | 2023-06-27 | 2023-06-29 | 346,723 | $25.23 | $8.75M | 346,723 | SEC↗ |
| GPCR Structure Therapeutics Inc | C Conversion deriv | 2023-02-07 | 2023-02-09 | 57,523 | — | $0 | 0 | SEC↗ |
| GPCR Structure Therapeutics Inc | C Conversion deriv | 2023-02-07 | 2023-02-09 | 965,115 | — | $0 | 0 | SEC↗ |
| GPCR Structure Therapeutics Inc | C Conversion deriv | 2023-02-07 | 2023-02-09 | 10,154 | — | $0 | 0 | SEC↗ |
| GPCR Structure Therapeutics Inc | C Conversion deriv | 2023-02-07 | 2023-02-09 | 414,621 | — | $0 | 0 | SEC↗ |
| GPCR Structure Therapeutics Inc | C Conversion deriv | 2023-02-07 | 2023-02-09 | 568,098 | — | $0 | 0 | SEC↗ |
| GPCR Structure Therapeutics Inc | C Conversion deriv | 2023-02-07 | 2023-02-09 | 7,411 | — | $0 | 0 | SEC↗ |
| GPCR Structure Therapeutics Inc | C Conversion deriv | 2023-02-07 | 2023-02-09 | 6,947 | — | $0 | 0 | SEC↗ |
| GPCR Structure Therapeutics Inc | C Conversion deriv | 2023-02-07 | 2023-02-09 | 214,663 | — | $0 | 0 | SEC↗ |
| GPCR Structure Therapeutics Inc | C Conversion deriv | 2023-02-07 | 2023-02-09 | 3,572,022 | — | $0 | 0 | SEC↗ |
| GPCR Structure Therapeutics Inc | C Conversion | 2023-02-07 | 2023-02-09 | 57,523 | — | $0 | 57,523 | SEC↗ |
| GPCR Structure Therapeutics Inc | C Conversion | 2023-02-07 | 2023-02-09 | 965,115 | — | $0 | 965,115 | SEC↗ |
| GPCR Structure Therapeutics Inc | C Conversion | 2023-02-07 | 2023-02-09 | 6,947 | — | $0 | 82,035 | SEC↗ |
| GPCR Structure Therapeutics Inc | C Conversion | 2023-02-07 | 2023-02-09 | 214,663 | — | $0 | 4,769,404 | SEC↗ |
| GPCR Structure Therapeutics Inc | C Conversion | 2023-02-07 | 2023-02-09 | 414,621 | — | $0 | 4,554,741 | SEC↗ |
| GPCR Structure Therapeutics Inc | C Conversion | 2023-02-07 | 2023-02-09 | 568,098 | — | $0 | 4,140,120 | SEC↗ |
| GPCR Structure Therapeutics Inc | C Conversion | 2023-02-07 | 2023-02-09 | 10,154 | — | $0 | 67,677 | SEC↗ |
| GPCR Structure Therapeutics Inc | C Conversion | 2023-02-07 | 2023-02-09 | 7,411 | — | $0 | 75,088 | SEC↗ |
| GPCR Structure Therapeutics Inc | C Conversion | 2023-02-07 | 2023-02-09 | 3,572,022 | — | $0 | 3,572,022 | SEC↗ |
| PRME Prime Medicine, Inc. | C Conversion deriv | 2022-10-24 | 2022-10-26 | 98,967 | — | $0 | 0 | SEC↗ |
| PRME Prime Medicine, Inc. | C Conversion deriv | 2022-10-24 | 2022-10-26 | 11,015 | — | $0 | 0 | SEC↗ |
| PRME Prime Medicine, Inc. | C Conversion deriv | 2022-10-24 | 2022-10-26 | 3,805,080 | — | $0 | 0 | SEC↗ |
| PRME Prime Medicine, Inc. | C Conversion deriv | 2022-10-24 | 2022-10-26 | 4,124,375 | — | $0 | 0 | SEC↗ |
| PRME Prime Medicine, Inc. | C Conversion deriv | 2022-10-24 | 2022-10-26 | 423,509 | — | $0 | 0 | SEC↗ |
| PRME Prime Medicine, Inc. | C Conversion | 2022-10-24 | 2022-10-26 | 98,967 | — | $0 | 98,967 | SEC↗ |
| PRME Prime Medicine, Inc. | C Conversion | 2022-10-24 | 2022-10-26 | 3,805,080 | — | $0 | 3,805,080 | SEC↗ |
| PRME Prime Medicine, Inc. | C Conversion | 2022-10-24 | 2022-10-26 | 423,509 | — | $0 | 4,228,589 | SEC↗ |
| PRME Prime Medicine, Inc. | C Conversion | 2022-10-24 | 2022-10-26 | 4,124,375 | — | $0 | 4,124,375 | SEC↗ |
| PRME Prime Medicine, Inc. | C Conversion | 2022-10-24 | 2022-10-26 | 11,015 | — | $0 | 109,982 | SEC↗ |
| BEAM Beam Therapeutics Inc. | J Other | 2022-09-06 | 2022-09-08 | 25,620 | — | $0 | 0 | SEC↗ |
| BEAM Beam Therapeutics Inc. | S Sale | 2022-09-06 | 2022-09-08 | 551 | $54.25 | $29.9K | 0 | SEC↗ |
| BEAM Beam Therapeutics Inc. | J Other | 2022-09-06 | 2022-09-08 | 551 | — | $0 | 551 | SEC↗ |
| BEAM Beam Therapeutics Inc. | S Sale | 2022-08-05 | 2022-08-08 | 167 | $61.00 | $10.2K | 0 | SEC↗ |
| BEAM Beam Therapeutics Inc. | S Sale | 2022-08-05 | 2022-08-08 | 20,159 | $60.50 | $1.22M | 0 | SEC↗ |
| BEAM Beam Therapeutics Inc. | J Other | 2022-08-04 | 2022-08-08 | 180,366 | — | $0 | 193,184 | SEC↗ |
| BEAM Beam Therapeutics Inc. | J Other | 2022-08-04 | 2022-08-08 | 800,000 | — | $0 | 2,135,511 | SEC↗ |
| BEAM Beam Therapeutics Inc. | J Other | 2022-08-04 | 2022-08-08 | 375,536 | — | $0 | 375,536 | SEC↗ |
| BEAM Beam Therapeutics Inc. | J Other | 2022-08-04 | 2022-08-08 | 312,512 | — | $0 | 2,803,027 | SEC↗ |
| BEAM Beam Therapeutics Inc. | J Other | 2022-08-04 | 2022-08-08 | 20,159 | — | $0 | 20,159 | SEC↗ |
| BEAM Beam Therapeutics Inc. | J Other | 2022-08-04 | 2022-08-08 | 167,564 | — | $0 | 25,620 | SEC↗ |
| BEAM Beam Therapeutics Inc. | J Other | 2022-08-04 | 2022-08-08 | 375,369 | — | $0 | 167 | SEC↗ |
| VERV Verve Therapeutics, Inc. | S Sale | 2022-07-12 | 2022-07-14 | 100,000 | $19.98 | $2.00M | 633,729 | SEC↗ |
| VERV Verve Therapeutics, Inc. | S Sale | 2022-07-12 | 2022-07-14 | 63,000 | $22.04 | $1.39M | 570,729 | SEC↗ |
| VERV Verve Therapeutics, Inc. | S Sale | 2022-07-01 | 2022-07-06 | 38,775 | $15.66 | $607.2K | 773,729 | SEC↗ |
| VERV Verve Therapeutics, Inc. | S Sale | 2022-06-30 | 2022-07-01 | 18,810 | $15.21 | $286.1K | 772,504 | SEC↗ |
| VERV Verve Therapeutics, Inc. | S Sale | 2022-06-29 | 2022-07-01 | 30,362 | $15.60 | $473.6K | 791,314 | SEC↗ |
| VERV Verve Therapeutics, Inc. | S Sale | 2022-06-29 | 2022-07-01 | 4,047 | $15.50 | $62.7K | 821,676 | SEC↗ |
| BEAM Beam Therapeutics Inc. | S Sale | 2022-04-13 | 2022-04-14 | 8,804 | $50.01 | $440.3K | 3,200 | SEC↗ |
| BEAM Beam Therapeutics Inc. | S Sale | 2022-04-13 | 2022-04-14 | 6,799 | $50.70 | $344.7K | 12,004 | SEC↗ |
| BEAM Beam Therapeutics Inc. | S Sale | 2022-04-13 | 2022-04-14 | 663 | $50.75 | $33.6K | 0 | SEC↗ |
| BEAM Beam Therapeutics Inc. | S Sale | 2022-04-13 | 2022-04-14 | 3,200 | $50.80 | $162.6K | 0 | SEC↗ |
| BEAM Beam Therapeutics Inc. | J Other | 2022-04-12 | 2022-04-14 | 15,406 | — | $0 | 18,803 | SEC↗ |
| BEAM Beam Therapeutics Inc. | J Other | 2022-04-12 | 2022-04-14 | 422,120 | — | $0 | 2,490,515 | SEC↗ |
| BEAM Beam Therapeutics Inc. | J Other | 2022-04-12 | 2022-04-14 | 128,333 | — | $0 | 12,818 | SEC↗ |
| BEAM Beam Therapeutics Inc. | J Other | 2022-04-12 | 2022-04-14 | 137,845 | — | $0 | 141,151 | SEC↗ |
| BEAM Beam Therapeutics Inc. | J Other | 2022-04-12 | 2022-04-14 | 509,332 | — | $0 | 663 | SEC↗ |
| BEAM Beam Therapeutics Inc. | J Other | 2022-04-12 | 2022-04-14 | 509,490 | — | $0 | 509,995 | SEC↗ |
| BEAM Beam Therapeutics Inc. | J Other | 2022-04-12 | 2022-04-14 | 978,503 | — | $0 | 2,935,511 | SEC↗ |
| VERV Verve Therapeutics, Inc. | S Sale | 2022-03-09 | 2022-03-11 | 3,971 | $29.01 | $115.2K | 825,723 | SEC↗ |
| VERV Verve Therapeutics, Inc. | S Sale | 2022-02-09 | 2022-02-11 | 13,190 | $29.46 | $388.6K | 829,694 | SEC↗ |
| VERV Verve Therapeutics, Inc. | S Sale | 2022-02-01 | 2022-02-03 | 35,574 | $29.04 | $1.03M | 842,884 | SEC↗ |
| VERV Verve Therapeutics, Inc. | S Sale | 2022-01-27 | 2022-01-28 | 8,736 | $29.26 | $255.6K | 878,705 | SEC↗ |
| VERV Verve Therapeutics, Inc. | S Sale | 2022-01-27 | 2022-01-28 | 247 | $30.02 | $7.4K | 878,458 | SEC↗ |
| VERV Verve Therapeutics, Inc. | S Sale | 2022-01-26 | 2022-01-28 | 45,946 | $31.96 | $1.47M | 887,441 | SEC↗ |
| VERV Verve Therapeutics, Inc. | S Sale | 2022-01-26 | 2022-01-28 | 14,918 | $29.67 | $442.6K | 1,022,376 | SEC↗ |
| VERV Verve Therapeutics, Inc. | S Sale | 2022-01-26 | 2022-01-28 | 88,989 | $31.12 | $2.77M | 933,387 | SEC↗ |
| XLO Xilio Therapeutics, Inc. | C Conversion deriv | 2021-10-26 | 2021-10-28 | 7,500,000 | — | $0 | 0 | SEC↗ |
| XLO Xilio Therapeutics, Inc. | C Conversion deriv | 2021-10-26 | 2021-10-28 | 6,521,739 | — | $0 | 0 | SEC↗ |
| XLO Xilio Therapeutics, Inc. | C Conversion deriv | 2021-10-26 | 2021-10-28 | 272,687 | — | $0 | 0 | SEC↗ |
| XLO Xilio Therapeutics, Inc. | C Conversion deriv | 2021-10-26 | 2021-10-28 | 3,536,046 | — | $0 | 0 | SEC↗ |
| XLO Xilio Therapeutics, Inc. | C Conversion deriv | 2021-10-26 | 2021-10-28 | 42,421 | — | $0 | 0 | SEC↗ |
| XLO Xilio Therapeutics, Inc. | C Conversion | 2021-10-26 | 2021-10-28 | 789,473 | — | $0 | 815,788 | SEC↗ |
| XLO Xilio Therapeutics, Inc. | C Conversion | 2021-10-26 | 2021-10-28 | 372,215 | — | $0 | 372,215 | SEC↗ |
| XLO Xilio Therapeutics, Inc. | C Conversion | 2021-10-26 | 2021-10-28 | 28,703 | — | $0 | 1,530,990 | SEC↗ |
| XLO Xilio Therapeutics, Inc. | C Conversion | 2021-10-26 | 2021-10-28 | 686,499 | — | $0 | 1,502,287 | SEC↗ |
| XLO Xilio Therapeutics, Inc. | C Conversion | 2021-10-26 | 2021-10-28 | 4,465 | — | $0 | 4,465 | SEC↗ |
| BEAM Beam Therapeutics Inc. | J Other | 2021-08-25 | 2021-08-26 | 969,038 | — | $0 | 304 | SEC↗ |
| BEAM Beam Therapeutics Inc. | J Other | 2021-08-25 | 2021-08-26 | 793,736 | — | $0 | 1,744,221 | SEC↗ |
| BEAM Beam Therapeutics Inc. | J Other | 2021-08-24 | 2021-08-26 | 969,189 | — | $0 | 969,342 | SEC↗ |
| BEAM Beam Therapeutics Inc. | J Other | 2021-08-24 | 2021-08-26 | 1,569 | — | $0 | 2,293 | SEC↗ |
| BEAM Beam Therapeutics Inc. | J Other | 2021-08-24 | 2021-08-26 | 16,153 | — | $0 | 0 | SEC↗ |
| BEAM Beam Therapeutics Inc. | J Other | 2021-08-24 | 2021-08-26 | 1,615,314 | — | $0 | 4,611,205 | SEC↗ |
| BEAM Beam Therapeutics Inc. | J Other | 2021-08-24 | 2021-08-26 | 16,153 | — | $0 | 16,153 | SEC↗ |
| BEAM Beam Therapeutics Inc. | J Other | 2021-08-09 | 2021-08-10 | 1,160,430 | — | $0 | 153 | SEC↗ |
| BEAM Beam Therapeutics Inc. | J Other | 2021-08-09 | 2021-08-16 | 950,485 | — | $0 | 950,485 | SEC↗ |
| BEAM Beam Therapeutics Inc. | J Other | 2021-08-09 | 2021-08-16 | 1,160,430 | — | $0 | 153 | SEC↗ |
| BEAM Beam Therapeutics Inc. | J Other | 2021-08-06 | 2021-08-10 | 7,454 | — | $0 | 0 | SEC↗ |
| BEAM Beam Therapeutics Inc. | J Other | 2021-08-06 | 2021-08-10 | 447,236 | — | $0 | 1,160,583 | SEC↗ |
| BEAM Beam Therapeutics Inc. | J Other | 2021-08-06 | 2021-08-10 | 724 | — | $0 | 724 | SEC↗ |
| BEAM Beam Therapeutics Inc. | J Other | 2021-08-06 | 2021-08-10 | 7,454 | — | $0 | 7,454 | SEC↗ |
| BEAM Beam Therapeutics Inc. | J Other | 2021-08-06 | 2021-08-10 | 745,393 | — | $0 | 6,226,519 | SEC↗ |
| BEAM Beam Therapeutics Inc. | J Other | 2021-08-06 | 2021-08-16 | 724 | — | $0 | 724 | SEC↗ |
| BEAM Beam Therapeutics Inc. | J Other | 2021-08-06 | 2021-08-16 | 745,393 | — | $0 | 6,226,519 | SEC↗ |
| BEAM Beam Therapeutics Inc. | J Other | 2021-08-06 | 2021-08-16 | 447,236 | — | $0 | 1,160,583 | SEC↗ |
| BEAM Beam Therapeutics Inc. | J Other | 2021-08-06 | 2021-08-16 | 7,454 | — | $0 | 0 | SEC↗ |
| BEAM Beam Therapeutics Inc. | J Other | 2021-08-06 | 2021-08-16 | 7,454 | — | $0 | 7,454 | SEC↗ |
| RLYB Rallybio Corp | C Conversion deriv | 2021-08-02 | 2021-08-04 | 10,789,193 | — | $0 | 0 | SEC↗ |
| RLYB Rallybio Corp | C Conversion | 2021-08-02 | 2021-08-04 | 1,694,388 | — | $0 | 1,694,388 | SEC↗ |
| CRBU Caribou Biosciences, Inc. | C Conversion deriv | 2021-07-27 | 2021-07-29 | 588,794 | — | $0 | 0 | SEC↗ |
| CRBU Caribou Biosciences, Inc. | C Conversion deriv | 2021-07-27 | 2021-07-29 | 9,666 | — | $0 | 0 | SEC↗ |
| CRBU Caribou Biosciences, Inc. | C Conversion deriv | 2021-07-27 | 2021-07-29 | 805,707 | — | $0 | 0 | SEC↗ |
| CRBU Caribou Biosciences, Inc. | C Conversion deriv | 2021-07-27 | 2021-07-29 | 423,823 | — | $0 | 0 | SEC↗ |
| CRBU Caribou Biosciences, Inc. | C Conversion | 2021-07-27 | 2021-07-29 | 770,510 | — | $0 | 770,510 | SEC↗ |
| CRBU Caribou Biosciences, Inc. | C Conversion | 2021-07-27 | 2021-07-29 | 1,070,427 | — | $0 | 1,840,937 | SEC↗ |
| CRBU Caribou Biosciences, Inc. | C Conversion | 2021-07-27 | 2021-07-29 | 17,572 | — | $0 | 17,572 | SEC↗ |
| CRBU Caribou Biosciences, Inc. | C Conversion | 2021-07-27 | 2021-07-29 | 1,464,775 | — | $0 | 1,464,775 | SEC↗ |
| VERV Verve Therapeutics, Inc. | C Conversion deriv | 2021-06-21 | 2021-06-23 | 8,361,204 | — | $0 | 0 | SEC↗ |
| VERV Verve Therapeutics, Inc. | C Conversion deriv | 2021-06-21 | 2021-06-23 | 1,243,626 | — | $0 | 0 | SEC↗ |
| VERV Verve Therapeutics, Inc. | C Conversion | 2021-06-21 | 2021-06-23 | 902,986 | — | $0 | 1,037,294 | SEC↗ |
| VERV Verve Therapeutics, Inc. | C Conversion | 2021-06-21 | 2021-06-23 | 134,308 | — | $0 | 134,308 | SEC↗ |
| FLYW Flywire Corp | C Conversion deriv | 2021-05-28 | 2021-06-02 | 19,434 | — | $0 | 0 | SEC↗ |
| FLYW Flywire Corp | C Conversion deriv | 2021-05-28 | 2021-06-02 | 420,024 | — | $0 | 0 | SEC↗ |
| FLYW Flywire Corp | C Conversion deriv | 2021-05-28 | 2021-06-02 | 4,183,071 | — | $0 | 0 | SEC↗ |
| FLYW Flywire Corp | C Conversion deriv | 2021-05-28 | 2021-06-02 | 1,500,435 | — | $0 | 0 | SEC↗ |
| FLYW Flywire Corp | C Conversion deriv | 2021-05-28 | 2021-06-02 | 1,145,526 | — | $0 | 0 | SEC↗ |
| FLYW Flywire Corp | C Conversion | 2021-05-28 | 2021-06-02 | 4,183,071 | — | $0 | 4,183,071 | SEC↗ |
| FLYW Flywire Corp | C Conversion | 2021-05-28 | 2021-06-02 | 1,145,526 | — | $0 | 5,328,597 | SEC↗ |
| FLYW Flywire Corp | C Conversion | 2021-05-28 | 2021-06-02 | 1,500,435 | — | $0 | 6,829,032 | SEC↗ |
| FLYW Flywire Corp | C Conversion | 2021-05-28 | 2021-06-02 | 420,024 | — | $0 | 7,249,056 | SEC↗ |
| FLYW Flywire Corp | C Conversion | 2021-05-28 | 2021-06-02 | 19,434 | — | $0 | 7,268,490 | SEC↗ |
| ORTX Orchard Therapeutics plc | C Conversion deriv | 2021-02-19 | 2021-02-23 | 409,852 | — | $0 | 1,000,000 | SEC↗ |
| ORTX Orchard Therapeutics plc | C Conversion deriv | 2021-02-19 | 2021-02-23 | 409,852 | — | $0 | 1,000,000 | SEC↗ |
| ORTX Orchard Therapeutics plc | C Conversion | 2021-02-19 | 2021-02-23 | 409,852 | — | $0 | 4,099,540 | SEC↗ |
| ORTX Orchard Therapeutics plc | C Conversion | 2021-02-19 | 2021-02-23 | 409,852 | — | $0 | 4,099,540 | SEC↗ |
| ORTX Orchard Therapeutics plc | S Sale | 2021-02-05 | 2021-02-10 | 1,022,755 | $6.98 | $7.14M | 5,099,540 | SEC↗ |
| ORTX Orchard Therapeutics plc | S Sale | 2021-02-05 | 2021-02-10 | 1,022,755 | $6.98 | $7.14M | 5,099,540 | SEC↗ |
| BEAM Beam Therapeutics Inc. | J Other | 2021-01-28 | 2021-02-01 | 356,673 | — | $0 | 713,347 | SEC↗ |
| BEAM Beam Therapeutics Inc. | J Other | 2020-08-07 | 2020-08-11 | 356,674 | — | $0 | 356,674 | SEC↗ |
| BEAM Beam Therapeutics Inc. | C Conversion deriv | 2020-02-10 | 2020-02-12 | 21,146,743 | — | $0 | 0 | SEC↗ |
| BEAM Beam Therapeutics Inc. | C Conversion deriv | 2020-02-10 | 2020-02-12 | 297,620 | — | $0 | 0 | SEC↗ |
| BEAM Beam Therapeutics Inc. | C Conversion deriv | 2020-02-10 | 2020-02-12 | 9,819,820 | — | $0 | 0 | SEC↗ |
| BEAM Beam Therapeutics Inc. | C Conversion | 2020-02-10 | 2020-02-12 | 2,189,820 | — | $0 | 6,971,912 | SEC↗ |
| BEAM Beam Therapeutics Inc. | C Conversion | 2020-02-10 | 2020-02-12 | 4,715,723 | — | $0 | 4,782,092 | SEC↗ |
| BEAM Beam Therapeutics Inc. | C Conversion | 2020-02-10 | 2020-02-12 | 66,369 | — | $0 | 66,369 | SEC↗ |
| ORTX Orchard Therapeutics plc | S Sale | 2020-01-02 | 2020-01-06 | 5,484 | $13.55 | $74.3K | 6,131,048 | SEC↗ |
| ORTX Orchard Therapeutics plc | S Sale | 2020-01-02 | 2020-01-06 | 5,484 | $13.55 | $74.3K | 6,131,048 | SEC↗ |
| ORTX Orchard Therapeutics plc | S Sale | 2020-01-02 | 2020-01-06 | 8,753 | $13.41 | $117.4K | 6,122,295 | SEC↗ |
| ORTX Orchard Therapeutics plc | S Sale | 2020-01-02 | 2020-01-06 | 8,753 | $13.41 | $117.4K | 6,122,295 | SEC↗ |
| DTIL PRECISION BIOSCIENCES INC | C Conversion deriv | 2019-04-01 | 2019-04-03 | 7,000,000 | — | $0 | 0 | SEC↗ |
| DTIL PRECISION BIOSCIENCES INC | C Conversion deriv | 2019-04-01 | 2019-04-03 | 873,253 | — | $0 | 0 | SEC↗ |
| DTIL PRECISION BIOSCIENCES INC | C Conversion | 2019-04-01 | 2019-04-03 | 3,279,170 | — | $0 | 3,279,170 | SEC↗ |
| DTIL PRECISION BIOSCIENCES INC | P Buy | 2019-04-01 | 2019-04-03 | 50,000 | $16.00 | $800.0K | 3,738,248 | SEC↗ |
| DTIL PRECISION BIOSCIENCES INC | C Conversion | 2019-04-01 | 2019-04-03 | 409,078 | — | $0 | 3,688,248 | SEC↗ |
| VRAY ViewRay, Inc. | S Sale | 2018-08-08 | 2018-08-10 | 200,000 | $10.02 | $2.00M | 604,736 | SEC↗ |
| VRAY ViewRay, Inc. | S Sale | 2018-08-07 | 2018-08-08 | 4,200 | $10.16 | $42.7K | 804,736 | SEC↗ |
| VRAY ViewRay, Inc. | S Sale | 2018-08-07 | 2018-08-08 | 11,400 | $10.12 | $115.4K | 808,936 | SEC↗ |
| VRAY ViewRay, Inc. | S Sale | 2018-08-07 | 2018-08-08 | 10,000 | $10.10 | $101.0K | 820,336 | SEC↗ |
| VRAY ViewRay, Inc. | S Sale | 2018-08-07 | 2018-08-08 | 1,000 | $10.38 | $10.4K | 830,336 | SEC↗ |
| VRAY ViewRay, Inc. | S Sale | 2018-08-06 | 2018-08-08 | 58,280 | $10.45 | $609.0K | 850,416 | SEC↗ |
| VRAY ViewRay, Inc. | S Sale | 2018-08-06 | 2018-08-08 | 19,550 | $10.59 | $207.0K | 946,615 | SEC↗ |
| VRAY ViewRay, Inc. | S Sale | 2018-08-06 | 2018-08-08 | 10,673 | $10.47 | $111.7K | 935,942 | SEC↗ |
| VRAY ViewRay, Inc. | S Sale | 2018-08-06 | 2018-08-08 | 24,367 | $10.64 | $259.3K | 911,575 | SEC↗ |
| VRAY ViewRay, Inc. | S Sale | 2018-08-06 | 2018-08-08 | 2,879 | $10.56 | $30.4K | 908,696 | SEC↗ |
| VRAY ViewRay, Inc. | S Sale | 2018-08-06 | 2018-08-08 | 5,700 | $10.68 | $60.9K | 966,165 | SEC↗ |
| VRAY ViewRay, Inc. | S Sale | 2018-08-06 | 2018-08-08 | 400 | $10.69 | $4.3K | 971,865 | SEC↗ |
| VRAY ViewRay, Inc. | S Sale | 2018-08-06 | 2018-08-08 | 6,400 | $10.48 | $67.1K | 972,265 | SEC↗ |
| VRAY ViewRay, Inc. | S Sale | 2018-08-06 | 2018-08-08 | 7,200 | $10.69 | $77.0K | 831,336 | SEC↗ |
| VRAY ViewRay, Inc. | S Sale | 2018-08-06 | 2018-08-08 | 2,980 | $10.77 | $32.1K | 838,536 | SEC↗ |
| VRAY ViewRay, Inc. | S Sale | 2018-08-06 | 2018-08-08 | 6,900 | $10.68 | $73.7K | 841,516 | SEC↗ |
| VRAY ViewRay, Inc. | S Sale | 2018-08-06 | 2018-08-08 | 2,000 | $10.48 | $21.0K | 848,416 | SEC↗ |
| VRAY ViewRay, Inc. | S Sale | 2018-08-03 | 2018-08-06 | 30,000 | $11.46 | $343.8K | 978,665 | SEC↗ |
| VRAY ViewRay, Inc. | S Sale | 2018-08-03 | 2018-08-06 | 225,153 | $11.25 | $2.53M | 1,008,665 | SEC↗ |
| VRAY ViewRay, Inc. | S Sale | 2018-08-02 | 2018-08-06 | 2,587 | $12.00 | $31.0K | 1,233,818 | SEC↗ |
| VRAY ViewRay, Inc. | S Sale | 2018-08-02 | 2018-08-06 | 64,900 | $11.95 | $775.6K | 1,248,440 | SEC↗ |
| VRAY ViewRay, Inc. | S Sale | 2018-08-02 | 2018-08-06 | 12,035 | $12.16 | $146.3K | 1,236,405 | SEC↗ |
| VRAY ViewRay, Inc. | S Sale | 2018-08-01 | 2018-08-02 | 7,600 | $11.91 | $90.5K | 1,313,340 | SEC↗ |
| VRAY ViewRay, Inc. | S Sale | 2018-08-01 | 2018-08-02 | 3,200 | $11.94 | $38.2K | 1,320,940 | SEC↗ |
| VRAY ViewRay, Inc. | S Sale | 2018-08-01 | 2018-08-02 | 778 | $11.95 | $9.3K | 1,324,140 | SEC↗ |
| VRAY ViewRay, Inc. | S Sale | 2018-08-01 | 2018-08-02 | 1,200 | $11.95 | $14.3K | 1,324,918 | SEC↗ |
| VRAY ViewRay, Inc. | S Sale | 2018-08-01 | 2018-08-02 | 8,600 | $11.93 | $102.6K | 1,326,118 | SEC↗ |
| VRAY ViewRay, Inc. | S Sale | 2018-08-01 | 2018-08-02 | 2,900 | $12.02 | $34.9K | 1,334,718 | SEC↗ |
| VRAY ViewRay, Inc. | S Sale | 2018-08-01 | 2018-08-02 | 1,000 | $12.18 | $12.2K | 1,337,618 | SEC↗ |
| VRAY ViewRay, Inc. | S Sale | 2018-08-01 | 2018-08-02 | 800 | $12.10 | $9.7K | 1,338,618 | SEC↗ |
| VRAY ViewRay, Inc. | S Sale | 2018-08-01 | 2018-08-02 | 3,000 | $12.13 | $36.4K | 1,339,418 | SEC↗ |
| VRAY ViewRay, Inc. | S Sale | 2018-08-01 | 2018-08-02 | 1,500 | $11.95 | $17.9K | 1,342,418 | SEC↗ |
| VRAY ViewRay, Inc. | S Sale | 2018-08-01 | 2018-08-02 | 35,756 | $12.11 | $433.0K | 1,343,918 | SEC↗ |
| VRAY ViewRay, Inc. | S Sale | 2018-07-31 | 2018-08-02 | 500 | $12.13 | $6.1K | 1,380,674 | SEC↗ |
| VRAY ViewRay, Inc. | S Sale | 2018-07-31 | 2018-08-02 | 6,522 | $12.11 | $79.0K | 1,381,174 | SEC↗ |
| VRAY ViewRay, Inc. | S Sale | 2018-07-31 | 2018-08-02 | 900 | $12.11 | $10.9K | 1,387,696 | SEC↗ |
| VRAY ViewRay, Inc. | S Sale | 2018-07-31 | 2018-08-02 | 30,000 | $12.12 | $363.6K | 1,388,596 | SEC↗ |
| VRAY ViewRay, Inc. | S Sale | 2018-07-31 | 2018-08-02 | 2,700 | $12.13 | $32.8K | 1,418,596 | SEC↗ |
| VRAY ViewRay, Inc. | S Sale | 2018-07-31 | 2018-08-02 | 19,250 | $12.07 | $232.3K | 1,421,296 | SEC↗ |
| VRAY ViewRay, Inc. | S Sale | 2018-07-31 | 2018-08-02 | 1,000 | $12.03 | $12.0K | 1,379,674 | SEC↗ |
| VRAY ViewRay, Inc. | S Sale | 2018-07-30 | 2018-07-31 | 11,500 | $11.39 | $131.0K | 1,450,546 | SEC↗ |
| VRAY ViewRay, Inc. | S Sale | 2018-07-30 | 2018-07-31 | 10,000 | $11.44 | $114.4K | 1,440,546 | SEC↗ |
| VRAY ViewRay, Inc. | S Sale | 2018-07-30 | 2018-07-31 | 6,000 | $11.45 | $68.7K | 1,541,991 | SEC↗ |
| VRAY ViewRay, Inc. | S Sale | 2018-07-30 | 2018-07-31 | 2,555 | $11.47 | $29.3K | 1,547,991 | SEC↗ |
| VRAY ViewRay, Inc. | S Sale | 2018-07-30 | 2018-07-31 | 253 | $11.36 | $2.9K | 1,530,138 | SEC↗ |
| VRAY ViewRay, Inc. | S Sale | 2018-07-30 | 2018-07-31 | 400 | $11.48 | $4.6K | 1,541,591 | SEC↗ |
| VRAY ViewRay, Inc. | S Sale | 2018-07-30 | 2018-07-31 | 7,800 | $11.48 | $89.5K | 1,533,791 | SEC↗ |
| VRAY ViewRay, Inc. | S Sale | 2018-07-30 | 2018-07-31 | 1,600 | $11.49 | $18.4K | 1,532,191 | SEC↗ |
| VRAY ViewRay, Inc. | S Sale | 2018-07-30 | 2018-07-31 | 1,200 | $11.54 | $13.8K | 1,530,991 | SEC↗ |